The Vermont Breast Cancer Surveillance System (VBCSS) proposes in this cooperative agreement application to continue membership in the multi-site National Cancer Institute's Breast Cancer Surveillance Consortium (BCSC). Our goal for this renewal is to continue to collect high quality data and encourage its use for breast cancer surveillance research and policy decisions. As the most rural state in the nation, Vermont is well suited to complement more urban sites currently represented in the NCI Consortium. In addition, with an ongoing statewide mammography-pathology registry coupled with a mandated state cancer registry, our site is well prepared to continue to actively contribute to and utilize surveillance data.
Our aims for this proposal are to: 1) maintain and improve a comprehensive, quality controlled, statewide surveillance system that accesses existing records and collects new information from mammography facilities, pathology laboratories, and a population-based cancer registry; 2) encourage use of site-specific and Breast Cancer Surveillance Consortium pooled data by local, national and international researchers from multiple disciplines and for diverse types of research and; 3) continue to actively participate in the NCI's Breast Cancer Surveillance Consortium through membership of the Steering Committee, telephone and in person meetings, and interact with the project director/scientists at NCI and with the staff and investigators at the Statistical Coordinating Center. ? ?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (M1))
Program Officer
Taplin, Stephen
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Vermont & St Agric College
Schools of Medicine
United States
Zip Code
Bodelon, Clara; Oh, Hannah; Chatterjee, Nilanjan et al. (2017) Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int J Cancer 140:825-832
Geller, Berta M; Nelson, Heidi D; Weaver, Donald L et al. (2017) Characteristics associated with requests by pathologists for second opinions on breast biopsies. J Clin Pathol 70:947-953
Onega, Tracy; Weaver, Donald L; Frederick, Paul D et al. (2017) The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer 80:39-47
Miglioretti, Diana L; Ichikawa, Laura; Smith, Robert A et al. (2017) Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. Acad Radiol 24:1256-1264
Frederick, Paul D; Nelson, Heidi D; Carney, Patricia A et al. (2017) The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making. Med Decis Making 37:91-100
Elmore, Joann G; Nelson, Heidi D; Pepe, Margaret S et al. (2016) Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med 164:649-55
Oh, Hannah; Bodelon, Clara; Palakal, Maya et al. (2016) Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue. Breast Cancer Res Treat 158:341-50
Carney, Patricia A; Allison, Kimberly H; Oster, Natalia V et al. (2016) Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation. Mod Pathol 29:717-26
Gierach, Gretchen L; Patel, Deesha A; Pfeiffer, Ruth M et al. (2016) Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. Cancer Prev Res (Phila) 9:149-58
Oh, Hannah; Khodr, Zeina G; Sherman, Mark E et al. (2016) Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. Horm Cancer 7:305-315

Showing the most recent 10 out of 184 publications